COVID-19 Vaccines: mRNA vs Traditional (2020)

by Anonymous

When COVID-19 struck, vaccine developers chose between proven traditional methods (inactivated virus, viral vector) and the untested-at-scale mRNA technology. Moderna and Pfizer's mRNA vaccines were the first to gain emergency authorization.

mRNA Vaccines (Pfizer/Moderna)

2020
year
11 months (record-breaking)
development speed
~95% against original strain
efficacy
First authorized — billions of doses administered
outcome

Viral Vector (AstraZeneca/J&J)

2020
year
12-14 months
development speed
60-70%
efficacy
Authorized — widely used globally
outcome

Inactivated Virus (Sinovac/Sinopharm)

2020
year
12-15 months
development speed
50-80%
efficacy
Used primarily in China and developing countries
outcome

Want to make your own version?

Sign up to create your own